Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 8 hrs 19 mins

S&P Futures
6,008.00
+4.25(+0.07%)
Dow Futures
43,925.00
+15.00(+0.03%)
Nasdaq Futures
21,254.25
+29.50(+0.14%)
Russell 2000 Futures
2,398.50
+2.80(+0.12%)
Crude Oil
71.89
-0.47(-0.65%)
Gold
2,701.50
-4.30(-0.16%)

Cross Country Healthcare, Inc. (CCRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

12.27

+0.12

(+0.99%)

At close: 04:00PM EST

12.27

0.00

(0.00%)

After hours:

04:20PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	400.00M
Enterprise Value	340.39M
Trailing P/E	59.84
Forward P/E	17.27
PEG Ratio (5 yr expected)	1.73
Price/Sales (ttm)	0.29
Price/Book (mrq)	0.94
Enterprise Value/Revenue	0.24
Enterprise Value/EBITDA	16.22

Trading Information

Stock Price History

Beta (5Y Monthly)	N/A
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	23.64
52 Week Low ³	11.02
50-Day Moving Average ³	13.09
200-Day Moving Average ³	15.75

Share Statistics

Avg Vol (3 month) ³	757.75k
Avg Vol (10 day) ³	510.76k
Shares Outstanding ⁵	32.6M
Implied Shares Outstanding ⁶	N/A
Float ⁸	30.96M
% Held by Insiders ¹	5.44%
% Held by Institutions ¹	107.72%
Shares Short (Oct 15, 2024) ⁴	3.11M
Short Ratio (Oct 15, 2024) ⁴	2.75
Short % of Float (Oct 15, 2024) ⁴	11.90%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	9.18%
Shares Short (prior month Sep 13, 2024) ⁴	4.11M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-0.12%
Operating Margin (ttm)	1.22%

Management Effectiveness

Return on Assets (ttm)	1.27%
Return on Equity (ttm)	-0.40%

Income Statement

Revenue (ttm)	1.45B
Revenue Per Share (ttm)	42.70
Quarterly Revenue Growth (yoy)	-28.80%
Gross Profit (ttm)	N/A
EBITDA	31.05M
Net Income Avi to Common (ttm)	-1.76M
Diluted EPS (ttm)	0.25
Quarterly Earnings Growth (yoy)	-80.10%

Balance Sheet

Total Cash (mrq)	64.02M
Total Cash Per Share (mrq)	1.94
Total Debt (mrq)	4.41M
Total Debt/Equity (mrq)	1.04
Current Ratio (mrq)	2.79
Book Value Per Share (mrq)	12.86

Cash Flow Statement

Operating Cash Flow (ttm)	107.96M
Levered Free Cash Flow (ttm)	114.03M